Search results
Results From The WOW.Com Content Network
The American Association of Clinical Endocrinology (AACE) is a professional community of physicians specializing in endocrinology, diabetes, and metabolism. [1] AACE's mission is elevating clinical endocrinology to improve global health. [2] The association is headquartered in Jacksonville, Florida, US. [3]
A phase III study of sunitinib treatment in well differentiated pNET that had worsened within the past 12 months (either advanced or metastatic disease) showed that sunitinib treatment improved progression-free survival (11.4 months vs. 5.5 months), overall survival, and the objective response rate (9.3% vs. 0.0%) when compared with placebo.
Endocrine Practice is a bimonthly peer-reviewed medical journal covering endocrinology. It was established in 1995, and is the official journal of the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE).
Prediabetes is a component of metabolic syndrome and is characterized by elevated blood sugar levels that fall below the threshold to diagnose diabetes mellitus.It usually does not cause symptoms but people with prediabetes often have obesity (especially abdominal or visceral obesity), dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. [1]
Type 3c diabetes (also known as pancreatogenic diabetes) is diabetes that comes secondary to pancreatic diseases, [1] involving the exocrine and digestive functions of the pancreas. It also occurs following surgical removal of the pancreas. Around 5–10% of cases of diabetes in the Western world are related to pancreatic diseases.
Surgery may follow neoadjuvant chemotherapy, which aims to shrink the tumor and increase the likelihood of complete resection. [8] Post-operative death and complications associated with pancreaticoduodenectomy have become less common, with rates of post-operative mortality falling from 30 to 10% in the 1980s to less than 5% in the 2000s. [9]
The glucose clamp technique was developed by University of Texas (UT) School of Medicine Professors DeFronzo, Andres and Tobin in 1979. [2] It has since been the gold standard for pharmacodynamic studies in diabetes drug development and diagnostics evaluation. [3]
AACE is the publisher of Cost Engineering, a bi-monthly technical journal, Skills and Knowledge of Cost Engineering (currently in its 6th edition), Source magazine (a bi-monthly magazine), 20 different AACE International Professional Practice Guides, approximately 120 Recommended Practices, and its most comprehensive publication, the Total Cost ...